GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Relmada Therapeutics RLMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.14

+6.15%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Relmada Therapeutics and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Relmada Therapeutics RLMD 4.14$124.9m——— +6.15%
Eton Pharmaceuticals ETON 64.35$1.73bn—-5.8%— +13.97%
Prothena Corporation PRTA 8.78$472.6m—-2520.6%— +10.16%
Flexion Therapeutics FLXN 24.07$1.19bn—-132.9%2.16% +0.92%
Lexeo Therapeutics LXEO 3.14$229.2m—-9063.8%— +8.65%
Zura Bio ZURA 1.24$91.4m——— -69.68%
Varex Imaging VREX 18.45$773.1m—-8.3%— +0.05%
AngioDynamics ANGO 12.12$499.6m—-11.5%— +3.32%
Aclaris Therapeutics ACRS 4.24$519.7m—-829.6%— +8.72%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.